(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -8.18%14.12M | 86.65%12.19M | -21.61%6.51M | -21.61%6.51M | -54.22%5.63M | 139.35%15.38M | 67.94%6.53M | 82.27%8.31M | 82.27%8.31M | 139.31%12.29M |
-Cash and cash equivalents | -8.18%14.12M | 86.65%12.19M | -21.61%6.51M | -21.61%6.51M | -54.22%5.63M | 139.35%15.38M | 67.94%6.53M | 82.27%8.31M | 82.27%8.31M | 139.31%12.29M |
-Accounts receivable | 17.04%71.37M | -7.88%60.36M | -13.37%62.57M | -13.37%62.57M | 21.18%78.77M | 11.77%60.98M | 7.67%65.52M | 24.05%72.23M | 24.05%72.23M | -20.13%65M |
-Other receivables | ---- | ---- | 15.54%14.02M | 15.54%14.02M | ---- | ---- | ---- | 59.86%12.13M | 59.86%12.13M | ---- |
Total current assets | 8.76%105.74M | -0.04%89.23M | -14.41%85.04M | -14.41%85.04M | 10.08%104.01M | 22.14%97.22M | 11.84%89.27M | 30.78%99.35M | 30.78%99.35M | -4.16%94.49M |
Non current assets | ||||||||||
-Accumulated depreciation | ---- | ---- | -1.76%-441.19M | -1.76%-441.19M | ---- | ---- | ---- | ---433.54M | ---433.54M | ---- |
Investment properties | ---- | ---- | -50.31%1.43M | -50.31%1.43M | 19.92%3.28M | 27.89%3.15M | 29.55%2.03M | 7,447.37%2.87M | 7,447.37%2.87M | --2.73M |
Investments and advances | ---- | ---- | -8.80%14.19M | -8.80%14.19M | ---- | ---- | ---- | --15.56M | --15.56M | ---- |
-Long term equity investment | 7.62%251.11M | -7.86%211.9M | -15.97%203.64M | -15.97%203.64M | 24.11%219.09M | 29.68%233.34M | 29.93%229.96M | 39.75%242.33M | 39.75%242.33M | -4.37%176.53M |
-Including:Available-for-sale securities | ---- | ---- | -50.31%1.43M | -50.31%1.43M | 19.92%3.28M | 27.89%3.15M | 29.55%2.03M | 7,447.37%2.87M | 7,447.37%2.87M | --2.73M |
Non current note receivables | 20.58%4.05M | 8.43%4.04M | -2.98%4.07M | -2.98%4.07M | -56.48%2.42M | -46.85%3.36M | -51.72%3.72M | -45.26%4.2M | -45.26%4.2M | --5.57M |
-Goodwill | -0.40%31.81M | -1.24%32.06M | -2.40%31.94M | -2.40%31.94M | 50.70%32.25M | 53.11%31.94M | 59.78%32.46M | 56.96%32.73M | 56.96%32.73M | 1.03%21.4M |
Regulatory assets | 17.04%71.37M | -7.88%60.36M | -13.37%62.57M | -13.37%62.57M | 21.18%78.77M | 11.77%60.98M | 7.67%65.52M | 24.05%72.23M | 24.05%72.23M | -20.13%65M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | 5.42%7.9M | 3.95%7.98M | 20.44%8.1M | 20.44%8.1M | 12.20%7.39M | 26.78%7.49M | 26.83%7.67M | 7.12%6.73M | 7.12%6.73M | -0.12%6.59M |
-Current capital lease obligation | 5.42%7.9M | 3.95%7.98M | 20.44%8.1M | 20.44%8.1M | 12.20%7.39M | 26.78%7.49M | 26.83%7.67M | 7.12%6.73M | 7.12%6.73M | -0.12%6.59M |
-accounts payable | ---- | ---- | -10.33%8.88M | -10.33%8.88M | ---- | ---- | ---- | -11.92%9.9M | -11.92%9.9M | ---- |
-Total tax payable | 8.52%326.81M | -3.59%285.56M | -10.26%276.14M | -10.26%276.14M | 27.98%291.06M | 32.50%301.16M | 32.80%296.18M | 41.62%307.72M | 41.62%307.72M | 0.85%227.42M |
-Dividends payable | ---- | ---- | 52.19%1.81M | 52.19%1.81M | ---- | ---- | ---- | 63.36%1.19M | 63.36%1.19M | ---- |
-Due to related parties current | ---- | ---- | -34.06%393K | -34.06%393K | ---- | ---- | ---- | 43.96%596K | 43.96%596K | ---- |
-Other payable | 58.62%2.58M | 113.16%3.95M | 30.17%2.64M | 30.17%2.64M | 16.87%2.11M | -15.24%1.62M | -18.47%1.85M | -21.02%2.03M | -21.02%2.03M | -35.95%1.81M |
Current accrued expenses | ---- | ---- | 27.61%19.94M | 27.61%19.94M | ---- | ---- | ---- | -25.13%15.62M | -25.13%15.62M | ---- |
Current deferred liabilities | 42.47%40.77M | 39.43%32.33M | 6.04%24.4M | 6.04%24.4M | 20.90%31.61M | 5.28%28.61M | -5.77%23.19M | 20.29%23.01M | 20.29%23.01M | -8.26%26.15M |
Current liabilities | 17.25%89.34M | 8.51%78.46M | 12.08%77.54M | 12.08%77.54M | 18.76%87.39M | 28.54%76.19M | 26.13%72.31M | 4.42%69.18M | 4.42%69.18M | -14.47%73.58M |
Non current liabilities | ||||||||||
-Long term debt | -18.94%11.44M | -20.02%12.13M | -14.41%13.2M | -14.41%13.2M | -18.83%12.97M | -12.31%14.11M | -7.79%15.17M | -13.19%15.42M | -13.19%15.42M | -20.02%15.98M |
Non current accrued expenses | 11.81%577.28M | 3.42%532.63M | 3.17%508.34M | 3.17%508.34M | 19.12%525.26M | 21.07%516.31M | 23.69%515.03M | 16.41%492.72M | 16.41%492.72M | 3.50%440.95M |
Long term provisions | 9.32%239.68M | -7.00%199.76M | -16.07%190.44M | -16.07%190.44M | 28.39%206.13M | 33.80%219.23M | 33.80%214.79M | 45.79%226.91M | 45.79%226.91M | -2.47%160.55M |
Total non current liabilities | 10.28%416.15M | -1.21%364.02M | -6.16%353.68M | -6.16%353.68M | 25.73%378.44M | 31.68%377.35M | 31.43%368.48M | 32.93%376.9M | 32.93%376.9M | -3.38%301.01M |
Shareholders'equity | ||||||||||
Share capital | -0.61%385.12M | -0.07%388.36M | -0.00%385.64M | -0.00%385.64M | -0.07%385.38M | 0.33%387.47M | 0.24%388.64M | 0.31%385.66M | 0.31%385.66M | 0.53%385.66M |
-common stock | -0.61%385.12M | -0.07%388.36M | -0.00%385.64M | -0.00%385.64M | -0.07%385.38M | 0.33%387.47M | 0.24%388.64M | 0.31%385.66M | 0.31%385.66M | 0.53%385.66M |
Additional paid-in capital | 6.14%21.18M | 7.02%19.98M | 10.49%22.32M | 10.49%22.32M | 10.77%21.24M | 9.38%19.95M | 7.25%18.67M | 4.37%20.2M | 4.37%20.2M | 2.10%19.18M |
Gains losses not affecting retained earnings | 42.43%21.41M | -1.28%17.6M | -28.46%13.75M | -28.46%13.75M | -8.29%17.97M | 32.87%15.03M | 115.60%17.83M | 98.33%19.22M | 98.33%19.22M | 122.11%19.59M |
Other equity interest | -2.96%20.24M | -3.12%16.68M | ---- | ---- | 14.09%19.61M | 12.08%20.86M | 14.15%17.22M | ---- | ---- | 42.45%17.19M |
Total equity | 10.38%721.46M | 2.72%661.91M | -0.28%647.64M | -0.28%647.64M | 18.06%669.32M | 21.57%653.61M | 22.02%644.37M | 22.46%649.44M | 22.46%649.44M | 3.34%566.94M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.